Geode Capital Management, LLC Brainstorm Cell Therapeutics Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCLI
# of Institutions
44Shares Held
12.1MCall Options Held
169KPut Options Held
30.6K-
Armistice Capital, LLC New York, NY7.92MShares$9.34 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$1.78 Million0.0% of portfolio
-
Black Rock Inc. New York, NY386KShares$455,9680.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA340KShares$401,3770.01% of portfolio
-
Weaver Consulting Group234KShares$276,5400.03% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $43.1M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...